HOME >> MEDICINE >> NEWS
Lilly studies try to shed light on impact of race

CHICAGO, June 1, 2007 -- Statistics show lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year. Equally devastating, lung cancer is the leading cause of cancer death in Hispanic men and the second leading cause of cancer death in Hispanic women. Researchers at Eli Lilly and Company are actively investigating the efficacy and safety of lung cancer treatments ALIMTA (pemetrexed for injection) and GEMZAR (gemcitabine HCl for injection) in treating non-small cell lung cancer (NSCLC) in African-Americans, Hispanics and other diverse populations.

Two retrospective Lilly studies were unveiled today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. They offered cursory insight into how a diverse group of patients respond to treatment with Lilly chemotherapeutic options. One study analyzed data of chemonave African-American patients with stage IIIB/IV NSCLC treated with GEMZAR in combination with carboplatin or paclitaxel (Taxol) versus patients taking carboplatin in combination with paclitaxel. The second study provided data from six previous trials for non-Caucasian patients with advanced or metastatic NSCLC treated with ALIMTA.

African-Americans are often underrepresented in clinical trials and, therefore, little is known about the possible impact of race on the utility of many medications, said Coleman Obasaju, M.D., Ph.D., United States oncology medical director of Lilly and the principal investigator of these two studies. Because lung cancer is a particularly devastating disease, and a growing concern in the African-American population, it was a logical starting point for our analysis.

The GEMZAR study released at ASCO analyzed overall survival data from a previous randomized Phase III trial in the treatment of NSCLC, viewing data outcomes and toxicity data of 128 African-Americans compa
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
1-Jun-2007


Page: 1 2 3

Related medicine news :

1. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
2. Lilly Foundation gift to Indiana University Cancer Center
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. International studies show high efficacy for HPV vaccine
5. Innovative device to treat brain cancer shows promise in early studies
6. Limiting eligibility for medical studies can omit women and African-Americans
7. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
8. DOE commits $27.5M for uranium contaminant transport field studies
9. Clinical studies evaluate potential treatments for mouth ulcers
10. Call for greater use of comparative effectiveness studies to help advance disease management
11. Americans still not eating enough fruits and vegetables, according to 2 recent studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/20/2019)... ... November 20, 2019 , ... Bihler 4Slide-NC® Safety Enclosures ... of which are potentially dangerous, due to the possibility of clothing being grabbed, ... which of these occurrences can lead to severe injuries. , The Bihler 4Slide-NC® ...
(Date:11/19/2019)... ... November 19, 2019 , ... From nourishing skin and ... consumers make and maintain healthy changes, just in time for the holidays. The ... and CBD Peppermint Oil Blend as well as updated its AMPED™ Hydrate drink. ...
(Date:11/19/2019)... SANGERFIELD, N.Y. (PRWEB) , ... November 19, 2019 , ... ... his first marathon with a bike ride along the Charles River in Boston. Days ... seemed familiar to him, yet he struggled to know exactly who all of them ...
(Date:11/19/2019)... ... ... “In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy ... on Amazon in the USA, Canada, and United Kingdom in 10 categories including Cell ... was named a hot new release in multiple categories including Cell Biology, Respiratory, and ...
(Date:11/19/2019)... ... November 19, 2019 , ... Bright Day Big Blocks, ... is announcing the launch of their Gift Of Play initiative. Organizations are encouraged ... theirs. , Co-Founders of Bright Day Big Blocks, Laurel Tucker and David Krishock decided ...
Breaking Medicine News(10 mins):
(Date:11/21/2019)... ... November 21, 2019 , ... ... management of ocular surface disease, today announced that FocalPoint Holdings, a privately-held ... selected as the preferred partner. FocalPoint Holdings and its subsidiaries will now ...
(Date:11/20/2019)... VANCOUVER, British Columbia (PRWEB) , ... November 20, ... ... Novel Proprietary Test Formulation on Organs Specific Biomarkers” by Inthirani Arul has been ... Kingdom in 3 categories including Brain, Cardiovascular, and Medical Atlases. , The ...
(Date:11/19/2019)... ... November 19, 2019 , ... There are ... to get and stay healthy and pain-free. Chiropractic is a healthcare field that ... also address the effects of these conditions on the body’s general health. , ...
Breaking Medicine Technology:
Cached News: